{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:24:56Z","timestamp":1789586696451,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The alignment between objective scores and patient-reported outcome measures (PROMs) is underexplored. This study aimed to assess changes in Nasal Polyp Score (NPS) and Sino-Nasal Outcome Test (SNOT) scores in chronic rhinosinusitis with nasal polyps (CRSwNP) patients undergoing dupilumab treatment and explore correlations between these scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>CRSwNP patients received dupilumab therapy for six months. SNOT-20 German Adapted Version (GAV)\/SNOT-22 scores were assessed weekly, and NPS was measured at baseline and after one, three, and six months. Correlations were analyzed using Spearman\u2019s rank correlation and regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>69 patients were included. After one, three and six months of dupilumab therapy, SNOT and NPS scores improved significantly. Correlation analysis of SNOT and NPS showed significant correlations only within the nasal subscores, along with a weak trend for SNOT-20. Absolute changes over time lacked significance. However, correlation analysis revealed significant associations between relative changes in SNOT score and NPS, irrespective of timing, and when stratified by baseline NPS of 8, 6, and 4 (<jats:italic>r<\/jats:italic> = -0.54, <jats:italic>p<\/jats:italic>\u2009=\u20090.01; <jats:italic>r<\/jats:italic> = -0.44, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; <jats:italic>r<\/jats:italic> = -0.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). This was supported by linear regression modeling, suggesting potential predictive capability of NPS reduction on relative SNOT score improvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Dupilumab therapy significantly improved subjective and objective CRSwNP scores, exhibiting weak correlations in absolute values for nasal subscores. Furthermore, evidence indicated a correlation between relative changes in SNOT score and NPS, substantiated by predictive capability. This might be due to subjective perception variability, highlighting the suitability of relative change correlation analysis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00405-024-08973-7","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T19:01:31Z","timestamp":1726945291000},"page":"207-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation of sino-nasal outcome test and nasal polyp score in dupilumab-treated chronic rhinosinusitis with nasal polyps"],"prefix":"10.1007","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7339-9144","authenticated-orcid":false,"given":"Tina","family":"Mauthe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Ryser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Br\u00fchlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Yalamanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs C.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Soyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"6","key":"8973_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2500\/aap.2019.40.4252","volume":"40","author":"JH Kwah","year":"2019","unstructured":"Kwah JH, Peters AT (2019) Nasal polyps and rhinosinusitis. Allergy Asthma Proc 40(6):380\u2013384","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"8973_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565\u2013572","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"8973_CR3","first-page":"343","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Huynh TMT, Vandeplas G, Joish VN, Mannent LP, Tomassen P et al (2019) The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology 57(5):343\u2013351","journal-title":"Rhinology"},{"key":"8973_CR4","doi-asserted-by":"crossref","unstructured":"Bachert C, Bhattacharyya N, Desrosiers M, Khan AH (2021) Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. :127\u2013134","DOI":"10.2147\/JAA.S290424"},{"issue":"4","key":"8973_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.anai.2019.12.001","volume":"124","author":"TM Laidlaw","year":"2020","unstructured":"Laidlaw TM, Buchheit KM (2020) Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol 124(4):326\u2013332","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"8973_CR6","first-page":"1434","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA (2022) Chronic Rhinosinusitis with nasal polyps: quality of life in the Biologics era. J Allergy Clin Immunology: Pract 10(6):1434\u201353e9","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"9","key":"8973_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1042\/CS20190281","volume":"137","author":"I Striz","year":"2023","unstructured":"Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania NA et al (2023) New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci (Lond) 137(9):727\u2013753","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"8973_CR8","first-page":"151","volume":"59","author":"PW Hellings","year":"2021","unstructured":"Hellings PW, Verhoeven E, Fokkens WJ (2021) State-of-the-art overview on biological treatment for CRSwNP. Rhinology 59(2):151\u2013163","journal-title":"Rhinology"},{"issue":"Suppl S29","key":"8973_CR9","first-page":"1","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on Rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1\u2013464","journal-title":"Rhinology"},{"issue":"1","key":"8973_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/all.13984","volume":"75","author":"C Bachert","year":"2020","unstructured":"Bachert C, Hellings PW, Mullol J, Hamilos DL, Gevaert P, Naclerio RM et al (2020) Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy 75(1):148\u2013157","journal-title":"Allergy"},{"key":"8973_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2147\/JAA.S363527","volume":"15","author":"C Hopkins","year":"2022","unstructured":"Hopkins C, Buchheit KM, Heffler E, Cohen NA, Olze H, Khan AH et al (2022) Improvement in Health-Related Quality of Life with Dupilumab in patients with moderate-to-severe asthma with Comorbid Chronic Rhinosinusitis with\/without nasal polyps: an analysis of the QUEST study. J Asthma Allergy 15:767\u2013773","journal-title":"J Asthma Allergy"},{"issue":"3","key":"8973_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE et al (2020) Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 146(3):595\u2013605","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8973_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S et al (2017) Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol 140(4):1024\u20131031e14","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8973_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W et al (2013) Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131(1):110\u2013116e1","journal-title":"J Allergy Clin Immunol"},{"key":"8973_CR15","doi-asserted-by":"crossref","unstructured":"Ta NH, Gao J, Philpott C (eds) (2021) A systematic review to examine the relationship between objective and patient-reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice. International forum of allergy & rhinology","DOI":"10.1002\/alr.22744"},{"issue":"10","key":"8973_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/alr.22976","volume":"12","author":"VK Rathi","year":"2022","unstructured":"Rathi VK, Scangas GA, Metson RB, Xiao R, Nshuti L, Dusetzina SB (2022) Out-of-pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population. Int Forum Allergy Rhinology 12(10):1295\u20131298","journal-title":"Int Forum Allergy Rhinology"},{"issue":"4","key":"8973_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jaad.2019.12.034","volume":"82","author":"H Khosravi","year":"2020","unstructured":"Khosravi H, Zhang S, Anderson AM, Ferris LK, Choudhary S, Patton T (2020) Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States. J Am Acad Dermatol 82(4):1023\u20131024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"8973_CR18","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jaci.2015.10.012","volume":"136","author":"L Rudmik","year":"2015","unstructured":"Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler ZM (2015) Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol 136(6):1532\u201340e2","journal-title":"J Allergy Clin Immunol"},{"key":"8973_CR19","doi-asserted-by":"crossref","unstructured":"Jeong SS, Chen T, Nguyen SA, Edwards TS, Schlosser RJ (2022) Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis. Rhinology","DOI":"10.4193\/Rhin22.011"},{"issue":"4","key":"8973_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/all.15650","volume":"78","author":"P Gevaert","year":"2023","unstructured":"Gevaert P, De Craemer J, Bachert C, Blauwblomme M, Chaker A, Cingi C et al (2023) European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis. Allergy 78(4):912\u2013922","journal-title":"Allergy"},{"issue":"1","key":"8973_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1067\/mhn.2002.121022","volume":"126","author":"JF Piccirillo","year":"2002","unstructured":"Piccirillo JF, Merritt MG Jr, Richards ML (2002) Psychometric and clinimetric validity of the 20-item sino-nasal outcome test (SNOT-20). Otolaryngology\u2014Head Neck Surg 126(1):41\u201347","journal-title":"Otolaryngology\u2014Head Neck Surg"},{"issue":"1","key":"8973_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00106-005-1347-6","volume":"55","author":"I Baumann","year":"2007","unstructured":"Baumann I, Blumenstock G, DeMaddalena H, Piccirillo J, Plinkert P (2007) Lebensqualit\u00e4t Bei Patienten Mit Chronischer Rhinosinusitis. HNO 55(1):42\u201347","journal-title":"HNO"},{"issue":"4","key":"8973_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3923\/jms.2017.162.166","volume":"17","author":"AN Usman","year":"2017","unstructured":"Usman AN (2017) Correlation between septal body and quality of life based on Sinonasal Outcome Test 20 (SNOT-20). J Med Sci 17(4):162\u2013166","journal-title":"J Med Sci"},{"issue":"5","key":"8973_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/lary.29766","volume":"132","author":"AH Khan","year":"2022","unstructured":"Khan AH, Reaney M, Guillemin I, Nelson L, Qin S, Kamat S et al (2022) Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps. Laryngoscope 132(5):933\u2013941","journal-title":"Laryngoscope"},{"issue":"2","key":"8973_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4193\/Rhino15.072","volume":"54","author":"S Toma","year":"2016","unstructured":"Toma S, Hopkins C (2016) Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology 54(2):129\u2013133","journal-title":"Rhinology"},{"key":"8973_CR26","unstructured":"Team RC (2016) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www R-project org\/"},{"issue":"8","key":"8973_CR27","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/all.14809","volume":"76","author":"I Agache","year":"2021","unstructured":"Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Sol\u00e0 I et al (2021) Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy 76(8):2337\u20132353","journal-title":"Allergy"},{"issue":"6","key":"8973_CR28","doi-asserted-by":"publisher","first-page":"E1770","DOI":"10.1002\/lary.29230","volume":"131","author":"S Fujieda","year":"2021","unstructured":"Fujieda S, Matsune S, Takeno S, Asako M, Takeuchi M, Fujita H et al (2021) The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with nasal polyps in Japan. Laryngoscope 131(6):E1770\u2013e7","journal-title":"Laryngoscope"},{"issue":"5","key":"8973_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","volume":"34","author":"C Hopkins","year":"2009","unstructured":"Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 34(5):447\u2013454","journal-title":"Clin Otolaryngol"},{"issue":"5","key":"8973_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/coa.13177","volume":"43","author":"KM Phillips","year":"2018","unstructured":"Phillips KM, Hoehle LP, Caradonna DS, Gray ST, Sedaghat AR (2018) Minimal clinically important difference for the 22-item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol 43(5):1328\u20131334","journal-title":"Clin Otolaryngol"},{"issue":"10","key":"8973_CR31","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/lary.24654","volume":"124","author":"AJ Psaltis","year":"2014","unstructured":"Psaltis AJ, Li G, Vaezeafshar R, Cho K-S, Hwang PH (2014) Modification of the lund-kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures. Laryngoscope 124(10):2216\u20132223","journal-title":"Laryngoscope"},{"key":"8973_CR32","doi-asserted-by":"crossref","unstructured":"Misirovs R, Chan R, Lipworth B (2023) SNOT-5 and SNOT-22 relationship with endoscopic and radiological scores in chronic rhinosinusitis with nasal polyps. Annals of Allergy, Asthma & Immunology","DOI":"10.1016\/j.anai.2023.11.011"},{"issue":"4","key":"8973_CR33","first-page":"496","volume":"62","author":"T Mauthe","year":"2024","unstructured":"Mauthe T, Meerwein CM, Ryser FS, Br\u00c3 Hlmann C, Yalamanoglu A, Steiner UC et al (2024) Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps. Rhinology 62(4):496\u2013505","journal-title":"Rhinology"},{"issue":"4","key":"8973_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/jcm9040925","volume":"9","author":"S Schneider","year":"2020","unstructured":"Schneider S, Campion NJ, Villazala-Merino S, Liu DT, Bartosik T, Landegger LD et al (2020) Associations between the quality of life and nasal polyp size in patients suffering from chronic rhinosinusitis without nasal polyps, with nasal polyps or aspirin-exacerbated respiratory disease. J Clin Med 9(4):925","journal-title":"J Clin Med"},{"issue":"3","key":"8973_CR35","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/lary.21394","volume":"121","author":"WR Ryan","year":"2011","unstructured":"Ryan WR, Ramachandra T, Hwang PH (2011) Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients. Laryngoscope 121(3):674\u2013678","journal-title":"Laryngoscope"},{"issue":"5","key":"8973_CR36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00405-019-05320-z","volume":"276","author":"D Dejaco","year":"2019","unstructured":"Dejaco D, Riedl D, Huber A, Moschen R, Giotakis AI, Bektic-Tadic L et al (2019) The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol 276(5):1355\u20131365","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"8973_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/alr.21683","volume":"6","author":"AS DeConde","year":"2016","unstructured":"DeConde AS, Bodner TE, Mace JC, Alt JA, Rudmik L, Smith TL (2016) Development of a clinically relevant endoscopic grading system for chronic rhinosinusitis using canonical correlation analysis. Int Forum Allergy Rhinology 6(5):478\u2013485","journal-title":"Int Forum Allergy Rhinology"},{"issue":"2","key":"8973_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2500\/ajra.2015.29.4140","volume":"29","author":"AR Sedaghat","year":"2015","unstructured":"Sedaghat AR, Gray ST, Caradonna SD, Caradonna DS (2015) Clustering of chronic Rhinosinusitis Symptomatology reveals Novel associations with Objective Clinical and demographic characteristics. Am J Rhinol Allergy 29(2):100\u2013105","journal-title":"Am J Rhinol Allergy"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08973-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:54:55Z","timestamp":1736970895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8973"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08973-7","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MBS is a consultant for Sanofi, GSK, Novartis, Astra Zeneca, and MSD unrelated to this study. UCS is a consultant for Sanofi, GSK, TAKEDA, BioCryst unrelated to this study. All other researchers involved assure that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Level 3 of Evidence.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Oxford centre for evidence-based medicine 2011"}}]}}